Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued
Target Price
The average target price of WGS is 162 and suggests 55% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell